MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DE CLERCQ, E.
Right arrow Articles by WITKOP, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DE CLERCQ, E.
Right arrow Articles by WITKOP, B.

Molecular Pharmacology, Vol 12, 1045-1051, Copyright © 1976 by the American Society for Pharmacology and Experimental Therapeutics

Antiviral Activity of Poly(7-deazainosinic acid)-Derived Complexes in Vitro and in Vivo

E. DE CLERCQ 1, V. G. EDY 1, P. F. TORRENCE 1, J. A. WATERS 1, and B. WITKOP 1

1 Rega Institute for Medical Research, University of Leuven, Leuven, Belgium, and Laboratory of Chemistry, National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20014

The antiviral activities and/or interferon-inducing abilities of poly(I)·poly(C), poly(I)·poly(br5C), poly(c7I)·poly(C), and poly(c7I)·poly(br5C) have been assessed in a variety of cell cultures (human, rabbit, and mouse) and animals (rabbits, mice). In cultured cells the compounds were also examined for inhibition of host cell macromolecule synthesis. Lethal effects were looked for in mice sensitized with lead acetate. Although the extent of antiviral activity of the polymers varied from one assay system to another, the following order of (decreasing) activity appeared applicable to all systems: poly(I)·poly(br5C) [unknown] poly(I)·poly(C) > poly(c7I)·poly(b5C) [unknown] poly(c7I)·poly(C). Poly(I)·poly(C) and poly(I)·poly(br5C) did not differ markedly in antiviral activity, interferon-inducing ability, or toxicity. However, in human skin fibroblasts, poly(I)·poly(br5C) was distinctly superior as an interferon inducer, especially at lower doses. Poly(c7I)·poly(C) was the least active of the four polymers and was also the most potent inhibitor of host cell macromolecule synthesis. Poly(c7I)·poly(br5C) equaled or even surpassed poly(I)·poly(C) in interferon-inducing activity in human skin fibroblasts; in animals, however, it proved definitely less active. In determining the antiviral behavior of the complexes studied, two effector mechanisms should be taken into account: interferon induction and inhibition of macromolecule biosynthesis. Which of these parameters will predominate would ultimately depend on the fate of the double-stranded complex after it has reacted with the cell.

Note:
ACKNOWLEDGMENTS The skillful technical assistance of Anita Van Lierde and Miette Stuyck and the editorial help of Janine Putzeys are gratefully acknowledged. The authors are indebted to Dr. Leonard Kohn, National Institutes of Health, for his help in determining sedimentation coefficients.

Submitted on March 10, 1976
Accepted on July 8, 1976







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1976 by the American Society for Pharmacology and Experimental Therapeutics